Peptide Solubility Guide — Solvents, pH & Reconstitution Troubleshooting

Most peptides discussed in the research and clinical spaces are water-soluble and reconstitute easily in bacteriostatic water. But not all. Hydrophobic sequences, lipopeptides, and certain modifications create solubility challenges that can waste expensive material if handled incorrectly.

Predicting solubility from sequence

A peptide's solubility is primarily determined by the ratio of charged/polar residues to hydrophobic residues:

Water-soluble (net charge ≥ +1 or ≤ –1):

Peptides with abundant Lys, Arg, His, Asp, or Glu residues are generally soluble at 1–10 mg/mL in aqueous solution. Most research peptides — BPC-157, Ipamorelin, CJC-1295, Selank, Semax — fall in this category.

Poorly soluble (net charge ~0, high hydrophobic content):

Peptides rich in Leu, Ile, Val, Phe, Trp, and Ala with few charged residues may resist aqueous dissolution. These include many cosmetic lipopeptides, certain antimicrobial peptides, and some cyclic peptides.

General rule: count the charged residues (K, R, H, D, E) versus the hydrophobic residues (L, I, V, F, W, A, M). If charged residues are < 25% of the total and the peptide is longer than ~8 amino acids, expect solubility issues in plain water.

Reconstitution solvents

Bacteriostatic water (BAC water)

pH: ~5.5
Best for: Most cationic and neutral-to-mildly-hydrophobic peptides
Preservative: 0.9% benzyl alcohol enables multi-dose vial use for 28 days
Use case: The default reconstitution solvent for subcutaneous injection peptides

Sterile water

pH: ~5.5–7.0
Best for: Same as BAC water when single-dose use is intended
Limitation: No preservative — use within 24 hours or discard

0.1% acetic acid

pH: ~3.0
Best for: Basic peptides (net positive charge) that are sluggish in neutral water. The acidic pH protonates histidine residues and improves solubility.
Common use: Glucagon, certain AMPs, GHRP-6

Dilute sodium hydroxide (0.1% NaOH)

pH: ~10
Best for: Acidic peptides (net negative charge). Deprotonates carboxyl-rich sequences.
Caution: Strongly basic conditions accelerate hydrolysis. Use as initial dissolution only, then dilute into neutral buffer.

DMSO (dimethyl sulfoxide)

Best for: Hydrophobic peptides insoluble in all aqueous solvents
Protocol: Dissolve peptide in minimum DMSO (typically 50–100 µL), then slowly dilute into aqueous buffer to final concentration
Limitation: DMSO at > 1% final concentration can be cytotoxic and is not suitable for injection. Limit final DMSO to < 0.5% for biological applications.

Step-by-step reconstitution for stubborn peptides

Try BAC water first. Add solvent gently down the vial wall. Let sit 5 minutes. Swirl gently — never shake vigorously.
If undissolved after 10 minutes: try gentle warming (30–37°C water bath) for 5 minutes. Mild heat increases kinetic energy and dissolution rate.
If still undissolved: add a small volume of 0.1% acetic acid (for basic peptides) or 0.1% NaOH (for acidic peptides). Typically 10–20 µL is sufficient.
If completely insoluble: dissolve in minimum DMSO, then dilute into aqueous buffer. This is the last resort.

Never sonicate peptide solutions — ultrasonic energy can fragment peptide bonds and cause aggregation.

Common peptide solubility reference

|---|---|---|---|

Concentration considerations

Too concentrated → aggregation, adsorption losses, potential precipitation
Too dilute → proportionally more peptide lost to vial-wall adsorption; larger injection volumes
Sweet spot for most research peptides: 1–5 mg/mL

For expensive peptides, reconstitute at higher concentrations to minimize relative adsorption losses, and use low-bind vials when available.

Signs of a solubility problem

Visible particles or cloudiness after reconstitution → undissolved peptide or aggregation
Gel formation → concentration too high or pH-induced aggregation
Rapid loss of efficacy → peptide may have precipitated out of solution over days

If you see any of these, do not inject. Reassess solvent choice and concentration.